These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32534258)

  • 21. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte.
    Chen JX; Li L; Cantrell AC; Williams QA; Zeng H
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
    Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte-specific knockout of HIF-2α cannot alleviate carbon tetrachloride-induced liver fibrosis in mice.
    Ye J; Chen J; Li Y; Sun L; Lu H
    PeerJ; 2023; 11():e15191. PubMed ID: 37033734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF Activation Against CVD in CKD: Novel Treatment Opportunities.
    Tanaka T; Eckardt KU
    Semin Nephrol; 2018 May; 38(3):267-276. PubMed ID: 29753402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons.
    Lomb DJ; Desouza LA; Franklin JL; Freeman RS
    Mol Pharmacol; 2009 May; 75(5):1198-209. PubMed ID: 19204094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
    Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis.
    Zhou LY; Zeng H; Wang S; Chen JX
    Cell Physiol Biochem; 2018; 48(3):1003-1011. PubMed ID: 30036883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-Inducible Factor-2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin-6.
    Gao RY; Wang M; Liu Q; Feng D; Wen Y; Xia Y; Colgan SP; Eltzschig HK; Ju C
    Hepatology; 2020 Jun; 71(6):2105-2117. PubMed ID: 31529728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of HIF-2α PAS-B domain contributes to physiological responses.
    Feng Z; Zou X; Chen Y; Wang H; Duan Y; Bruick RK
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13240-13245. PubMed ID: 30523118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M.
    Poblete JMS; Ballinger MN; Bao S; Alghothani M; Nevado JB; Eubank TD; Christman JW; Magalang UJ
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E689-E700. PubMed ID: 32154744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing radiation-induced gastrointestinal toxicity - the role of the PHD/HIF axis.
    Olcina MM; Giaccia AJ
    J Clin Invest; 2016 Oct; 126(10):3708-3715. PubMed ID: 27548524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
    Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
    Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
    Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging.
    Mayer M; Fey K; Heinze E; Wick CR; Abboud MI; Yeh TL; Tumber A; Orth N; Schley G; Buchholz B; Clark T; Schofield CJ; Willam C; Burzlaff N
    ChemMedChem; 2019 Jan; 14(1):94-99. PubMed ID: 30380199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.